论文部分内容阅读
以新三两半口服液对儿童反复呼吸道感染的临床疗效作了观察。结果提示：新三两半口服液防治儿童反复呼吸道感染有效率为97.1％，与空白对照组比较差异非常显著，P＜0．001。新三两半口服液能明显提高血清IgA、IgG，服医药前后对比差并非常显著，P值分别＜0．01，＜0．05；并能改善某些血清微量元素缺乏，服药前后对比差异亦非常显著。新三两半口服液组方简便，具有健脾养血、益气固表等功效，服用方便，无毒副反应。
The clinical efficacy of recurrent respiratory tract infections in children with new 32 and a half oral liquid was observed. The results suggest that the effective rate of New Sanbanshe Oral Liquid in preventing and treating recurrent respiratory tract infections in children is 97.1%, which is significantly different from that of the blank control group (P <0.001). The new two and a half half oral liquid can significantly increase serum IgA, IgG, taking medicine before and after the contrast difference is very significant, P values were <0.01, <0.05; and can improve the lack of certain serum trace elements, before and after taking the contrast Also very significant. The new two and a half half oral solution group is simple, with spleen nourishing, Qi solid table and other effects, taking convenient, non-toxic side effects.